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Abstract
Background: Delirium in patients with hip fractures lead to higher morbidity and mortality. Prevention in high-risk
patients by prescribing low dose haloperidol is currently under investigation.
Methods: This prospective cohort surveillance assessed hip fracture patients for risk of developing a delirium with
the Risk Model for Delirium (RD) score. High-risk patients (score ≥ 5 points) were treated with a prophylactic low-
dose of haloperidol according to hospital protocol. Primary outcome was delirium incidence. Secondary outcomes
were differences between high- and low-risk patients in delirium, length of stay (LOS), return to pre-fracture living
situation and mortality. Logistic regression analysis was performed with age, ASA-classification, known dementia,
having a partner, type of fracture, institutional residence and psychotropic drug use as possible confounders.
Results: 445 hip fracture patients aged 65 years and older were admitted from January 2008 to December 2009.
The RD-score was completed in 378 patients, 173 (45.8%) high-risk patients were treated with prophylactic
medication. Sensitivity was 71.6%, specificity 63.8% and the negative predictive value (NPV) of a score < 5 was
85.9%.
Delirium incidence (27.0%) was not significantly different compared to 2007 (27.8%) 2006 (23.9%) and 2005 (29.0%)
prior to implementation of the RD- protocol.
Logistic regression analysis showed that high-risk patients did have a significant higher delirium incidence (42.2%
vs. 14.1%, OR 4.1, CI 2.43-7.02). They were more likely to be residing at an alternative living situation after 3 months
(62.3% vs. 17.0%, OR 6.57, CI 3.23-13.37) and less likely to be discharged from hospital before 10 days (34.9% vs.
55.9%, OR 1.63, CI 1.03-2.59). Significant independent risk factors for a delirium were a RD-score ≥ 5 (OR 4.13, CI
2.43-7.02), male gender (OR 1.93, CI 0.99-1.07) and age (OR 1.03, CI 0.99-1.07).
Conclusions: Introducing the delirium prevention protocol did not reduce delirium incidence.
The RD-score did identify patients with a high risk to develop a delirium. This high-risk group had a longer LOS
and returned to pre-fracture living situation less often.
The NPV of a score < 5 was high, as it should be for a screening instrument. Concluding, the RD-score is a useful
tool to identify patients with poorer outcome.
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Background
Delirium is a common and serious complication in hip
fracture patients. It leads to lower functional abilities,
longer hospital stay, impaired cognitive function, more
admissions to long term special care facilities and higher
mortality rates [1-5]. This advocates the importance of
preoperative delirium risk assessment.
Reported post-operative incidence rates range widely
from 16 to 62% [6]. This broad range can be explained
by patient inclusion criteria and different scoring meth-
ods for delirium. Furthermore, delirium is frequently
undetected or misdiagnosed [7].
Haloperidol is widely used for symptomatic treatment
of delirium. However, prophylaxis with haloperidol did
not lower delirium incidence, it did reduce duration of
episodes and the severity in a recent randomized con-
trolled trial [8].
In 2008 we introduced an integrated hip fracture care
pathway that included a Risk Model for Delirium [9].
This model should identify high-risk patients that are
subsequently prescribed prophylactic haloperidol. Pri-
mary purpose of this surveillance study was to deter-
mine whether using prophylaxis would diminish
delirium incidence in hip fracture patients. The second
aim was to investigate the value of the score and differ-
ences between low- and high-risk patients (as deter-
mined by the risk model) in delirium incidence, length
of stay, return to pre-fracture living situation and
mortality.
Methods
A surveillance was conducted on a series of consecutive
admissions for a hip fracture to a 450-bed teaching hos-
pital in Delft, the Netherlands.
Patients
From January 2008 to December 2009, all consecutive
admissions for a hip fracture were registered and pro-
spectively studied with respect to presence of delirium.
Thus 529 admissions (522 patients) were recorded.
These were all patients with a hip fracture due to a low-
energy trauma and of non-pathologic origin. For this
study, patients of 65 years and older (445 patients) were
included for evaluation. Duration of follow-up was 1
year.
The control group for evaluating the effect of the use
of the Risk Model for Delirium (RD-score) was a histori-
cal consecutive series of 611 hip fracture patients of 65
years and older admitted between 2005-2007, prior to
implementation of our RD protocol.
As this study is an evaluation of our delirium protocol,
it is considered to be a “Post Marketing Surveillance”.
Therefore, approval of a medical ethical committee was
not necessary.
Assessment measures
Uniformed data collection of all patients was achieved
by evaluating all patients on admission in a standard
procedure and recording, according to our local hip
fracture protocol [9]. The following data was collected
of all patients; age, gender, having a partner, history of
dementia, RD-score, pre-fracture living situation, ASA
classification [10], psychotropic drug use, type of frac-
ture, treatment and anaesthesia, in-hospital complica-
tions, discharge location, in hospital mortality and
length of stay (LOS).
Diagnosis of delirium was based on criteria of the
DSM IV [1]. Patients were observed for these criteria by
both doctors and nursing staff during their daily rounds
and assessments. When signs of delirium were notified,
they were recorded in the medical and nursing records.
Delirium incidence in this series was scored based on
these medical and nursing staff records, directly after
discharge. Living situation was assessed at 3 months
post-admission by questionnaires sent to all patients.
Mortality was assessed until 1 year after hospitalisation,
using the digital registration system of the hospital.
Delirium incidence in the historical group (2005-2007)
was drawn from our hip fracture database that was built
retrospectively by evaluation of the patients’ files and
complication register.
Assessing the risk for a delirium at admission, using the
RD-model (table 1), is a standard part of our local hip frac-
ture protocol [9]. This model was developed in 2004 by
the department of Psychiatry in our hospital and uses pre-
disposing risk factors for delirium that were weighted,
based on known literature at that moment [11-17]. The
model was designed with a cut-off point of 5; patients
scoring 5 or more points were considered high-risk
Table 1 The Risk Model for Delirium
Predisposing risk factors for delirium Points
Delirium during previous hospitalization 5
Dementia 5
Clock drawing (displaying 10 past 11)
- Small mistakes 1
- Big mistakes, unrecognizable or no attempt 2
Age
- 70 to 85 years 1
- Older than 85 years 2
Impaired hearing (patient is not able to hear speech) 1
Impaired vision (vision less than 40%) 1
Problems in activities of daily live
- Domestic help or help with meal preparation 0.5
- Help with physical care 0.5
Use of heroin, methadone or morphine 2
Daily consumption of 4 or more alcoholic beverages 2
Total score
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patients. For this group delirium prophylaxis is prescribed,
being 2 times a day 1 mg of haloperidol. In the case of
contra-indications for the use of haloperidol, like Parkin-
son’s disease or Lewy-body dementia, alternative prophy-
laxis was started. When patients developed a delirium,
they were fully assessed to exclude a somatic cause and
treated by the psychiatric department. The RD-score and
the delirium protocol were implemented fully on the
departments of Orthopaedics and Trauma surgery in
2008, as a part of the integrated hip fracture care pathway.
Outcome
The current cohort was analyzed for differences between
low- (< 5) and high-risk (≥ 5) patients for delirium inci-
dence, length of stay (LOS), alternative living situation
(ALS) 3 months post-fracture (compared to the pre-frac-
ture situation) and in-hospital, 3- and 12-month mortality.
Statistical analysis
Categorical data are presented as the number of sub-
jects, along with the percentages. Continuous data are
presented as means with standard deviations (SD). The
value of the RD-score was evaluated using sensitivity,
specificity, the negative predictive value of a low score
and the positive predictive value of a high score.
Chi-square test, Fisher’s exact test and independent
Student’s t-test were used as applicable for univariate
analysis. A P-value lower than 0.05 was taken as the
threshold of significance. LOS was divided in two
groups at the level of the median (10 days).
The ability of the RD to discriminate was estimated by
the receiver-operating characteristic (ROC) curve.
Univariate analysis was followed by multivariable
logistic regression to test the association between the
RD and delirium, mortality (in-hospital, 3 and 12-
month), LOS, and ALS at 3 months. In these analyses
age, gender, ASA score (I/II versus III/IV), psychotropic
drug use, institutional residence and known dementia
were seen as possible confounders. The analysis regard-
ing return to the pre-fracture living situation was per-
formed on patients that lived independent at home
before they broke their hip. To this analysis “having a
partner” was added as an extra possible confounder.
The likelihood ratio backward test was conducted to
find the best-fit model by selecting the variables one by
one. The probability for entry was set at 0.05, the prob-
ability for removal at 0.10.




In 378 of the 445 patients (85%) the RD-score was com-
pleted correctly. A delirium was diagnosed in 102 of
them (27.0%). Due to the inability of patients to partici-
pate or a patient-to-nurse ratio that was too high at
some moments, the RD-score was incomplete or not
performed in 67 patients.
These 67 discarded patients, as of an incomplete RD-
score, had a delirium incidence of 28.4%, not signifi-
cantly different from study cohort (P = 0.816). Further-
more, there was no difference in age (82.4 vs. 83.8 years;
P = 0.168), nor LOS (15.0 vs. 13.2 days, P = 0.172) and
1-year mortality (35.8% vs. 24.9%, P = 0.061) between
the completed RD and non-completed RD-score groups.
Historical comparison
The mean age of the prospective cohort 2008-2009 (83.7
years) was not significantly different from the historical
cohort 2005-2007 (82.9 years) (P = 0.082) The percen-
tage of male patients was 26.2% in the prospective
cohort and 24.3% in the historical cohort were the same
as well (P = 0.515). No significant differences in delir-
ium incidence were found between the prospective
2008/2009 (27%) and the historical cohorts; 2005
(29.0%, P = 0.28), 2006 (23.9%, P = 0.81) and 2007
(27.8%, P = 0.44). (Chi Square-test)
RD protocol
The protocol was violated in 49 out of 378 patients
(13%); prophylaxis was not started in 26 patients with a
score of ≥ 5 and was started in 23 patients scoring < 5.
Delirium incidence in the 23 low-risk patients was
34.8%, significantly higher than in the 182 that were not
prescribed prophylaxis, 11.5%. (Pearson Chi-Square, P =
0.003). Delirium incidence in the 26 high-risk patients
not started on prophylaxis was 50.0%, not significantly
higher than in the 147 that were prescribed prophylaxis,
40.8%. (Pearson Chi-Square, P = 0.38) When the proto-
col violations were excluded, high-risk patients still had
a higher risk of delirium (P < 0.001), a longer LOS (P <
0.001) a higher likelihood of living at an alternative liv-
ing situation after 3 months (P = 0.001) and higher
mortality rates at 3 and 12 months (P < 0.001).
Value of the RD-score
A receiver-operating characteristic (ROC) curve (Figure
1), made of the continuous outcome of the RD-score
showed an area under curve of 0.722 (CI 0.674-0.767, P
< 0.0001)The best cut-off point for balancing sensitivity
and specificity was 5, corresponding with the pre-study
chosen cut-off point.
Sensitivity of the cut-off point was 71.6% (73/102), speci-
ficity was 63.8% (176/276). Excluding patients who were
not treated according to the protocol, the sensitivity
became 74.1% (60/81) and the specificity 64.9% (161/248).
The negative predictive value of a score < 5 (i.e. no
delirium) was 85.9% (176/205), the positive predictive
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value for a score of ≥ 5 (i.e. delirium) was 42.2% (73/
173)
High- and low-risk patients
Specific details of 205 low-risk (score < 5) and 173 high-
risk (score of ≥ 5) patients are shown in table 2. High-
risk patients were significantly older, more often female,
suffering from dementia, ASA classification III-IV, hav-
ing no partner, residing in an institution, using psycho-
tropic drugs and receiving spinal/epidural anesthesia
during surgery.
At univariate analysis (table 2), patients with a RD-
score of ≥ 5 had a higher risk for a delirium, (P <
0.001). Furthermore, they had a longer LOS, a higher
chance of living at an alternative living situation after 3
months and a higher 3- and 12-month mortality rate
(all P < 0.001).
Multivariable analysis per outcome variable is dis-
played in table 3. The RD-score was a significantly con-
tributing variable for delirium, length of stay and
alternative living situation at 3 months. Age and ASA
classification were strong independently contributing
variable as well.
Discussion
Identification of hip fracture patients at risk for delirium
is important in order to start early treatment with medi-
cation and psycho-geriatric consultation. Therefore, it is
of great value to have an accurate but simple to use,
screening instrument.
We used the Risk Model for Delirium (RD-score) to
identify patients at risk for delirium and started
prophylactic haloperidol in the high-risk group. Large
differences between high- and low-risk patients regard-
ing delirium incidence, length of stay, discharge location
and mortality were anticipated. However in this study,
prophylactic treatment of high-risk patients as identified
by our RD-score, did not reduce delirium incidence
compared to our historical data. The score did indentify
patients with poorer outcome regarding delirium inci-
dence, LOS and return to pre-fracture living situation.
The RD-score had a moderate sensitivity (71.6%) and
specificity (63.8%), this is in accordance with other risk
models [18]. The negative predictive value (NPV) of a
score < 5 was quite high (85.9%), which is very impor-
tant as a screening instrument should have a high NPV.
The consequence of a false positive test (i.e. prophylactic
treatment with low-dosis haloperidol in a non-delirious
patient) is generally modest as very few side effects of a
low dose of haloperidol can be expected. Therefore, its
moderate positive predictive value (42.2%) is of lesser
importance.
The pre-study chosen cut-off value for the RD-score
of 5 was confirmed to be right by the ROC curve analy-
sis. This cut-off point provided a high-risk group with a
significant higher relative risk of developing a delirium;
OR (adjusted for age and gender) 4.13. Higher age and
ASA classification, residing in an institution and absence
of a partner suggested a higher vulnerability of the high-
risk group. This is demonstrated in outcome; high-risk
patients had a longer hospital stay, higher 3- and 12-
month mortality, and a higher risk of staying at an alter-
native living situation at 3 months in univariate analysis.
In multivariable analysis, the effect of the RD-score for
mortality disappeared.
Several authors described a model that tried to iden-
tify high-risk patients for delirium. One study used a
cohort of vascular surgery patients [18], another major
elective (non-cardiac) surgery patients [15] and 4 others
used cardiac surgery cohorts [19-22]. All these models
contained items that were not applicable to our patients,
while they were patient group specific and designed for
an elective surgery population. Kalisvaart et al [8] used a
population that contained both elective hip surgery and
hip fracture patients. They used visual impairment, dis-
ease severity (expressed by the Apache II score) [23],
mental impairment (Mini Mental State Examination,
MMSE) [24] and dehydration (expressed by blood urea
nitrogen/creatinine ratio) as parameters. We chose to
develop a simpler model that was easy to use in an
acute admission, to achieve maximum use in daily prac-
tice. This has been accomplished; 85% of all patients
had a complete RD-score. Despite the integration of the
RD in a standard patient file, the prophylaxis protocol
was violated in 13% of patients. High turnover of
screening score








Figure 1 ROC curve of the RD-score with 95% confidence
intervals. The diagonal indicate results no better than chance.
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Table 2 Relative risks for different demographic characteristics and outcome parameters with a RD- score ≥ 5
(univariate analysis)
Score ≥ 5 Score < 5 Relative risk (CI) P value
(n = 173) (n = 205)
Age, mean ± SD 86.6 ± 6.5 81.4 ± 7.1 n/a < 0.001***
Female gender 79.2% 69.3% 1.35 (1.01-1.80) 0.029
Dementia 51.4% 0% 3.44 (2.87-4.12) < 0.001
ASA -III-IV 45.7% 22.9% 1.68 (1.36-2.07) < 0.001
Institutional residence 61.8% 10.2% 3.17 (2.54-3.95) < 0.001
Having no partner 79.3% 60.9% 1.74 (1.26-2.41) < 0.001
Psychotropic drug use 51.4% 24.4% 1.82 (1.47-2.25) < 0.001
Fracture type
neck of femur 56.1% 59.0% 0.85*
(inter) trochanteric 39.5% 37.0% 0.95 (0.78-1.15) 0.59**
subtrochanteric 4.4% 4.0%
Treatment
osteosynthesis 60.5% 50.3% 0.077*
(hemi-) arthroplasty 38.5% 46.8% 1.19 (0.98-1.44) 0.072**
conservative 1.0% 9%
Spinal/epidural anesthesia 97.5% 91.1% 2.26 (1.05-4.85) 0.006
Delirium 42.4% 14.1% 1.98 (1.62-2.41) < 0.001
Length of stay ≥ 10 days 65.1% 44.1% 1.61 (1.27-2.05) < 0.001
Alternative living situation at 3 months* 62.3% 17.0% 4.25 (2.65-6.80) < 0.001
In-hospital mortality 5.8% 2.0% 1.60 (1.12-2.26) 0.050
3-month mortality 23.1% 8.3% 1.69 (1.37-2.10) < 0.001
12-month mortality 37.0% 14.6% 1.77 (1.45-2.17) < 0.001
* Only calculated for the patients not yet living in institutions (n = 218, n = 32 missing), * Comparing 3 treatment groups; ** RR and p-value comparing femur
neck with (inter) trochanteric fractures and osteosynthesis with arthroplasty; *** Independent T-test, CI = confidence interval
Table 3 Results of the multivariable logistic regression analysis per outcome variable
Outcome variable Independent variables Odds ratio 95% CI P value
Delirium Screening score ≥ 5 4.13 2.43-7.02 < 0.001
Age in years 1.03 0.99-1.07 0.082
Male gender 1.93 1.10-3.39 0.022
Length of hospital stay ≥ 10 days Screening score ≥ 5 1.63 1.03-2.59 0.037
Age in years 1.06 1.03-1.10 < 0.001
ASA III-IV 1.55 0.97-2.47 0.069
Alternative living situation at 3 months Screening score ≥ 5 6.57 3.23.-13.37 < 0.001
Age in years 1.09 1.04-1.06 0.001
In-hospital mortality Age in years 1.14 1.03-1.26 0.014
ASA III-IV 3.83 1.13-13.0 0.031
Institutional residence 3.54 0.89-14.0 0.072
3-month mortality Age in years 1.11 1.05-1.17 < 0.001
ASA III-IV 2.48 1.33-4.61 0.004
Institutional residence 2.97 1.55-5.68 0.001
12-month mortality Age in years 1.08 1.03-1.12 0.002
ASA III-IV 2.78 1.60-4.84 < 0.001
Having no partner 2.22 1.07-4.61 0.033
Institutional residence 2.06 1.16-3.68 0.014
Female, having a partner, ASA I-II, screening score < 5, not residing in an institution are reference categories
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doctors in the emergency department may have contrib-
uted to these violations.
Older age, cognitive impairment, use of psychotropic
drugs (for example benzodiazepines), functional impair-
ment (both in daily activity and clock drawing) visual
and hearing impairment were all included parameters
that were found to be associated with delirium in a sys-
tematic review by Dasgupta et al [25]. Besides these,
they found depression, psychopathologic symptoms, psy-
chotropic drugs, institutional residence and medical co-
morbidity to be important delirium risk factors. We
used institutional residence as a possible confounder in
regression analysis, which was of non-significant contri-
bution to risk for a delirium. However, it was a strong
predictor of mortality at 3 and 12 months. Psychotropic
drug use was associated with a RD-score ≥ 5, but not a
predictor of delirium or other outcome in multivariable
analysis.
Base on our analysis, adding the factor “male gender”
to the RD-score might improve its efficacy as this was a
significant contributor to delirium (OR 1.93). This is in
contrast to Dasgupta et al [25] who did not find a corre-
lation between male gender and delirium.
Twenty-three low-risk patients were prescribed halo-
peridol prophylaxis, against the protocol. This group
had a higher percentage of delirium than the rest of the
low-risk group, which was not hypothesized. The doctor
that prescribed haloperidol against protocol might be
triggered by patient factors that are not taken into con-
sideration by the score but that do predispose to a delir-
ium as they have a higher delirium incidence.
The prospective character of the study, its large sam-
ple size and the use of a predefined risk-stratification
model are important issues for interpretation of our
results. The main limitations are the subjectivity of
determining a delirium and mental impairment of a
patient. In our study, delirium was diagnosed based on
clinical examination, as stated in the DSM IV [1]. We
did not use a measuring instrument like a Confusion
Assessment Method [7] to establish delirium. A second
limitation was, that in cognitively impaired patients it is
difficult to distinguish between delirium and cognitive
impairment. Furthermore, patients were scored for
known dementia based on history taking and informa-
tion from digital patient files, a cognitive impairment
score like the MMSE was not used [24]. Another limita-
tion is the comparison of the delirium incidence in the
whole cohort with the historical cohort. Ideally, we
would have compared only the high-risk groups of both
cohorts. However, we could not identify high-risk
patients in the historical group as the RD-score was
implemented fully in 2008. We did demonstrate that
both cohorts were comparable regarding mean age and
number of male patients, being the main risk factors in
the multivariable analysis of the prospective cohort,
besides a high RD-score. Therewith one could have
observed a decline in delirium incidence due to prophy-
laxis with haloperidol.
Haloperidol is widely used for symptomatic treatment of
delirium, as prophylaxis it has a more disputable reputa-
tion. In one small study in gastrointestinal surgery
patients, haloperidol prophylaxis was proved effective in
reducing delirium incidence [26]. However, a large study
in hip fracture patients [8] did not support this finding.
Our protocol was developed with the intention to reduce
delirium incidence by earlier identification of patients at
risk with an objective scoring system, the RD-score. Com-
pared to our historical data, however, we saw no decline in
delirium incidence. This corresponded with a recent
Cochrane review [27] on interventions preventing delir-
ium. It stated that pro-active geriatric consultation could
reduce delirium incidence, but that low-dose haloperidol
prophylaxis did not diminish delirium rates [27]. Kalisvaart
et al. [8] showed that low-dose haloperidol prophylaxis can
reduce severity and duration of delirium and that this may
shorten LOS. During the study period, we started using
the Delirium Observation Scale [28] to monitor depth and
duration of a delirium. However, this instrument was not
yet used in a consistent way over the study period to take
these data in account for this analysis. Further research
should focus more on depth and duration of delirium
instead of incidence, since this might give better inside in
efficacy of prophylactic treatment. We believe that more
emphasis should be given on non-pharmalogical interven-
tions to prevent a delirium. These interventions include
providing orientation with calendars, clocks and photo-
graphs and maintain day-night rhythm. However, they
take valuable manpower from the nursing staff. When
these interventions can be targeted to the high-risk group
(as identified with the RD-score) it would be preferable.
Conclusions
Prescribing Profylactic haloperidol to high-risk patients
as identified by the Risk Model for Delirium did not
reduce delirium incidence in a cohort of hip fracture
patients.
The RD-score did prove to be an accurate tool for
indentifying high-risk patients with poorer outcome
regarding delirium incidence, length of stay and return
to pre-fracture living situation.
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